본문 바로가기
KERD
논문KCI 등재

Updates in postural tachycardia syndrome

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류신경과학

초록

Postural tachycardia syndrome (POTS) is the most common form of orthostatic intolerance in young people. However, it is still considered an underrecognized disorder and so deserves more attention from clinicians. This review covers the diagnostic challenges, correlations between the symptoms, evidence of autoimmune involvement in the pathogenesis, and treatment strategies in POTS.

Abstract

Postural tachycardia syndrome (POTS) is the most common form of orthostatic intolerance in young people. However, it is still considered an underrecognized disorder and so deserves more attention from clinicians. This review covers the diagnostic challenges, correlations between the symptoms, evidence of autoimmune involvement in the pathogenesis, and treatment strategies in POTS.

참고문헌 (44)

  1. Bryarly M, "Postural orthostatic tachycardia syndrome: JACC focus seminar", J Am Coll Cardiol, 73, pp.1207~1228 (2019)
  2. Mathias CJ, "Postural tachycardia syndrome—current experience and concepts", Nat Rev Neurol, 8, pp.22~34 (2011)
  3. Moon J, "Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome", Health Qual Life Outcomes, 14, pp.144~ (2016)
  4. Pandian JD, "Postural orthostatic tachycardia syndrome : an underrecognized disorder", Intern Med J, 37, pp.529~535 (2007)
  5. Lkhagvasuren B, "Prevalence of postural orthostatic tachycardia syndrome in patients with psychiatric disorders", Psychother Psychosom, 80, pp.308~309 (2011)
  6. Benarroch EE, "Postural tachycardia syndrome : a heterogeneous and multifactorial disorder", Mayo Clin Proc, 87, pp.1214~1225 (2012)
  7. Bagai K, "Sleep disturbances and diminished quality of life in postural tachycardia syndrome", J Clin Sleep Med, 7, pp.204~210 (2011)
  8. Reynolds GK, "Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort", J Intern Med, 275, pp.409~417 (2014)
  9. Lewis I, "Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome", J Intern Med, 273, pp.501~510 (2013)
  10. Karas B, "The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents", Pacing Clin Electrophysiol, 23, pp.344~351 (2000)
  11. Benrud-Larson LM, "Quality of life in patients with postural tachycardia syndrome", Mayo Clin Proc, 77, pp.531~537 (2002)
  12. Schmidt LL, "Postural orthostatic tachycardia syndrome (POTS): assess, diagnose, and evaluate for POTS treatment (ADEPT)", Integr Med Int, 4, pp.142~153 (2017)
  13. Sheldon RS, "2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope", Heart Rhythm, 12, pp.e41~e63 (2015)
  14. Freeman R, "Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome", Clin Auton Res, 21, pp.69~72 (2011)
  15. Emily M. Garland, "Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance", Current Neurology and Neuroscience Reports, 15(9) (2015), Springer Science and Business Media LLC[DOI]
  16. Brewster JA, "Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome", Clin Sci(Lond), 122, pp.25~31 (2012)
  17. Moon J, "The complexity of diagnosing postural orthostatic tachycardia syndrome : influence of the diurnal variability", J Am Soc Hypertens, 10, pp.263~270 (2016)
  18. Li H, "Autoimmune basis for postural tachycardia syndrome", J Am Heart Assoc, 3, pp.e000755~ (2014)
  19. Blitshteyn S, "Postural tachycardia syndrome(POTS)with anti-NMDA receptor antibodies after human papillomavirus vaccination", Immunol Res, 65, pp.282~284 (2017)
  20. Brinth L, "Suspected side effects to the quadrivalent human papilloma vaccine", Dan Med J, 62, pp.A5064~ (2015)
  21. Brinth LS, "Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus", Vaccine, 33, pp.2602~2605 (2015)
  22. Blitshteyn S, "Postural tachycardia syndrome after vaccination with Gardasil", Eur J Neurol, 17, pp.e52~ (2010)
  23. Blitshteyn S, "Postural tachycardia syndrome following human papillomavirus vaccination", Eur J Neurol, 21, pp.135~139 (2014)
  24. Kinoshita T, "Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine", Intern Med, 53, pp.2185~2200 (2014)
  25. Dahan S, "Postural orthostatic tachycardia syndrome(POTS)–a novel member of the autoimmune family", Lupus, 25, pp.339~342 (2016)
  26. Ruzieh M, "The role of autoantibodies in the syndromes of orthostatic intolerance : a systematic review", Scand Cardiovasc J, 51, pp.243~247 (2017)
  27. Fedorowski A, "Antiadrenergic autoimmunity in postural tachycardia syndrome", Europace, 19, pp.1211~1219 (2017)
  28. Vernino S, "Autoimmunity in postural orthostatic tachycardia syndrome : current understanding", Auton Neurosci, 215, pp.78~82 (2018)
  29. Blitshteyn S, "Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome(POTS)", Lupus, 24, pp.1364~1369 (2015)
  30. Shin YW, "Human leukocyte antigen associations in postural tachycardia syndrome", Ann Clin Transl Neurol, 6, pp.962~967 (2019)
  31. Li H, "Adrenergic autoantibody-induced postural tachycardia syndrome in rabbits", J Am Heart Assoc, 8, pp.e013006~ (2019)
  32. Miller AJ, "Hop to it : The first animal model of autoimmune postural orthostatic tachycardia syndrome", J Am Heart Assoc, 8, pp.e014084~ (2019)
  33. Zhang Q, "Update of individualized treatment strategies for postural orthostatic tachycardia syndrome in children", Front Neurol, 11, pp.525~ (2020)
  34. Joyner MJ, "Exercise training in postural orthostatic tachycardia syndrome: blocking the urge to block β-receptors?", Hypertension, 58, pp.136~137 (2011)
  35. Wieling W, "Nonpharmacological treatment of reflex syncope", Clin Auton Res, 14(Suppl 1), pp.i62~i70 (2004)
  36. Grubb BP, "Postural tachycardia syndrome", Circulation, 117, pp.2814~2817 (2008)
  37. Sousa A, "Long-term follow-up of patients with postural tachycardia syndrome", Clin Auton Res, 22, pp.151~153 (2012)
  38. Raj SR, "Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome less is more", Circulation, 120, pp.725~734 (2009)
  39. Freitas J, "Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone", Clin Auton Res, 10, pp.293~299 (2000)
  40. Kanjwal K, "Pyridostigmine in the treatment of postural orthostatic tachycardia : a single-center experience", Pacing Clin Electrophysiol, 34, pp.750~755 (2011)
  41. Hoeldtke RD, "Treatment of postural tachycardia syndrome : a comparison of octreotide and midodrine", Clin Auton Res, 16, pp.390~395 (2006)
  42. Miller AJ, "Pharmacotherapy for postural tachycardia syndrome", Auton Neurosci, 215, pp.28~36 (2018)
  43. Moon J, "Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial", Neurotherapeutics, 15, pp.785~795 (2018)
  44. Chen L, "Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome", Circ J, 75, pp.927~931 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (9건)